Business · 05/09/2023Updated: 10/17/2026 · 1 min read
FDA to Hold Public Meeting on Reauthorization of Over-the-Counter Monograph Drug User Fee Program
Summary
The FDA is seeking public input on proposed recommendations for reauthorizing the program that assesses and collects fees for OTC monograph drugs from FY 2026 to 2030, with a public meeting scheduled to discuss the proposal.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →